Search research articles
Contact Us
Filters
Showing results (261-270 of 412) with videos related to
Page
of 42
Sort By:
Cancer Immunology, Immunotherapy : CII
|
May 23, 2021
Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer
Victor M Schuettfort, Benjamin Pradere, Quoc-Dien Trinh, et al.
European Urology Focus
|
September 26, 2021
Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysis
Hadi Mostafaei, Hanieh Salehi-Pourmehr, Sandra Jilch, et al.
World Journal of Urology
|
June 18, 2021
Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer
Satoshi Katayama, Keiichiro Mori, Benjamin Pradere, et al.
Journal of Clinical Medicine
|
February 11, 2021
Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis
Wojciech Krajewski, Łukasz Nowak, Marco Moschini, et al.
Minerva Urology and Nephrology
|
July 26, 2021
Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile
Keiichiro Mori, Fahad Quhal, Satoshi Katayama, et al.
Urologic Oncology
|
March 4, 2022
The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis
Judith Stangl-Kremser, Gianluca Muto, Antonio Andrea Grosso, et al.
Nature Reviews. Urology
|
September 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies
Lexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess, et al.
European Urology Oncology
|
June 24, 2026
Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials
Pietro Scilipoti, Aleksander Ślusarczyk, Constance Thibault, et al.
Cells
|
August 9, 2020
Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer
Dafina Ilijazi, Walter Pulverer, Iris E Ertl, et al.
European Urology Focus
|
June 30, 2022
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines
Judith Stangl-Kremser, Luca Lambertini, Fabrizio Di Maida, et al.
Page
of 42
Search research articles
Search
Showing results (261-270 of 412) with videos related to
Sort By:
Page
of 42
Cancer Immunology, Immunotherapy : CII
|
May 23, 2021
Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer
Victor M Schuettfort, Benjamin Pradere, Quoc-Dien Trinh, et al.
European Urology Focus
|
September 26, 2021
Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysis
Hadi Mostafaei, Hanieh Salehi-Pourmehr, Sandra Jilch, et al.
World Journal of Urology
|
June 18, 2021
Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer
Satoshi Katayama, Keiichiro Mori, Benjamin Pradere, et al.
Journal of Clinical Medicine
|
February 11, 2021
Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis
Wojciech Krajewski, Łukasz Nowak, Marco Moschini, et al.
Minerva Urology and Nephrology
|
July 26, 2021
Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile
Keiichiro Mori, Fahad Quhal, Satoshi Katayama, et al.
Urologic Oncology
|
March 4, 2022
The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis
Judith Stangl-Kremser, Gianluca Muto, Antonio Andrea Grosso, et al.
Nature Reviews. Urology
|
September 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies
Lexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess, et al.
European Urology Oncology
|
June 24, 2026
Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials
Pietro Scilipoti, Aleksander Ślusarczyk, Constance Thibault, et al.
Cells
|
August 9, 2020
Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer
Dafina Ilijazi, Walter Pulverer, Iris E Ertl, et al.
European Urology Focus
|
June 30, 2022
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines
Judith Stangl-Kremser, Luca Lambertini, Fabrizio Di Maida, et al.
Page
of 42